IDH2 and cancer: Because IDH mutations alter NADP+/NADPH ratios and NADPH is a cofactor in recycling ascorbate, it is possible that vitamin C availability and D-2-HG accumulation have a combinatorial effect towards the dampened TET activity witnessed in IDH mutant cancers.